Deals
BioBlast Pharma Raises $7M at 24% Discount via Roth Capital Partners
|
BioBlast Pharma Limited (NASDAQ GM:ORPN) announced that it has raised $6,696,000 in a Registered Direct transaction.
Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/7/)
BioBlast Pharma Limited (NASDAQ GM:ORPN) announced that it has raised $6,696,000 in a Registered Direct transaction.
International Stem Cell Corporation (OTC:ISCO) announced that it has raised $6,310,000 in a Convertible Preferred Stock transaction.
Capricor Therapeutics(NASDAQ CM:CAPR) announced that it has raised $4,061,162 in a Registered Direct transaction.
Avant Diagnostics, Amarantus BioScience Holdings' diagnostics unit and Theranostics Health Inc. are merging so that the two makers of medical tests can take advantage of Theranostics's sales channel.